Oxolotl Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Ebitda
- Net Worth -0.65%
- Total Assets %
About Oxolotl Biotechnologies
Oxolotl Biotechnologies Private Limited (OBPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 August 2016 (Eight years and five months 28 days old ). Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Diwate and Deepali Diwate serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U52100PN2016PTC165829
- Company No.
165829
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Oxolotl Biotechnologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Diwate  | Director | 01-Aug-2019 | Current |
| Deepali Diwate | Director | 01-Aug-2019 | Current |
Financial Performance of Oxolotl Biotechnologies.
Oxolotl Biotechnologies Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Oxolotl Biotechnologies?
Unlock access to Oxolotl Biotechnologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nutrigold Healthtech LlpPradeep Diwate and Deepali Diwate are mutual person
- Rnglab (India) Private Limited
Pradeep Diwate is a mutual person
- Biodiagnotech Healthcare Solutions Private Limited
Pradeep Diwate and Deepali Diwate are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Oxolotl Biotechnologies?
Unlock and access historical data on people associated with Oxolotl Biotechnologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oxolotl Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oxolotl Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
